Innate Pharma SA is a global, clinical-stage biotechnology company, which engages in developing immunotherapies for cancer patients. Its product pipeline includes Lacutamab, Monalizumab, Avdoralimab, and IPH62. The company was founded by Hervé Eloi Dominique Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fournié, and François Romagné on September 23, 1999 and is headquartered in Marseille, France.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
181
Frequently Asked Questions
What is Market Cap of Innate Pharma - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Innate Pharma - ADR market cap is $191.7M.
What is the 52-week high for Innate Pharma - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Innate Pharma - ADR 52 week high is $3.51 as of September 17, 2025.
What is the 52-week low for Innate Pharma - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Innate Pharma - ADR 52 week low is $1.29 as of September 17, 2025.
What is Innate Pharma - ADR stock price today?
Innate Pharma - ADR stock price today is $2.08.
What was Innate Pharma - ADR stock price yesterday?
Innate Pharma - ADR stock price yesterday was $2.08.
What is the PE ratio of Innate Pharma - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Innate Pharma - ADR’s P/E ratio is -3.15.
What is the Price-to-Book ratio of Innate Pharma - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Innate Pharma - ADR P/B ratio is 19.0581.
What is the 50-day moving average of Innate Pharma - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Innate Pharma - ADR 50-day moving average is $2.05.
